Clinical Trial Update: MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkin's Lymphoma. [Phase 4]

View source ↗

Summary

Phase 4 study evaluating maintenance rituximab (MabThera) in patients with Non-Hodgkin's Lymphoma has completed; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• MabThera (rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Non-Hodgkin's Lymphoma | Phase 4 | Status: COMPLETED | Results posted: 2015-06-08